nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerating the discovery of antibacterial compounds using pathway-directed whole cell screening
|
Matano, Leigh M. |
|
2016 |
24 |
24 |
p. 6307-6314 8 p. |
artikel |
2 |
A cell-based approach to characterize antimicrobial compounds through kinetic dose response
|
MacNair, Craig R. |
|
2016 |
24 |
24 |
p. 6315-6319 5 p. |
artikel |
3 |
A Gestalt approach to Gram-negative entry
|
Silver, Lynn L. |
|
2016 |
24 |
24 |
p. 6379-6389 11 p. |
artikel |
4 |
Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents
|
Zhao, Miao |
|
2016 |
24 |
24 |
p. 6390-6400 11 p. |
artikel |
5 |
Antibacterial sulfur-containing platensimycin and platencin congeners from Streptomyces platensis SB12029
|
Dong, Liao-Bin |
|
2016 |
24 |
24 |
p. 6348-6353 6 p. |
artikel |
6 |
Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products
|
Molloy, Evelyn M. |
|
2016 |
24 |
24 |
p. 6276-6290 15 p. |
artikel |
7 |
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus
|
Ngo, Huy X. |
|
2016 |
24 |
24 |
p. 6298-6306 9 p. |
artikel |
8 |
Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase
|
Singh, Sheo B. |
|
2016 |
24 |
24 |
p. 6291-6297 7 p. |
artikel |
9 |
Discovery of novel antibacterials
|
Romesberg, Floyd E. |
|
2016 |
24 |
24 |
p. 6225-6226 2 p. |
artikel |
10 |
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic
|
Tanaka, S. Ken |
|
2016 |
24 |
24 |
p. 6409-6419 11 p. |
artikel |
11 |
Drug discovery strategies to outer membrane targets in Gram-negative pathogens
|
Brown, Dean G. |
|
2016 |
24 |
24 |
p. 6320-6331 12 p. |
artikel |
12 |
Editorial board
|
|
|
2016 |
24 |
24 |
p. IFC- 1 p. |
artikel |
13 |
From lead optimization to NDA approval for a new antimicrobial: Use of pre-clinical effect models and pharmacokinetic/pharmacodynamic mathematical modeling
|
Drusano, G.L. |
|
2016 |
24 |
24 |
p. 6401-6408 8 p. |
artikel |
14 |
Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides
|
Bugg, Timothy D.H. |
|
2016 |
24 |
24 |
p. 6340-6347 8 p. |
artikel |
15 |
New antibiotics from Nature’s chemical inventory
|
Wencewicz, Timothy A. |
|
2016 |
24 |
24 |
p. 6227-6252 26 p. |
artikel |
16 |
Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence
|
Walsh, Shawn I. |
|
2016 |
24 |
24 |
p. 6370-6378 9 p. |
artikel |
17 |
Plazomicin is effective in a non-human primate pneumonic plague model
|
Mega, William M. |
|
2016 |
24 |
24 |
p. 6429-6439 11 p. |
artikel |
18 |
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ
|
Haranahalli, Krupanandan |
|
2016 |
24 |
24 |
p. 6354-6369 16 p. |
artikel |
19 |
Regulatory Incentives for Antibiotic Drug Development: A Review of Recent Proposals
|
Sinha, Michael S. |
|
2016 |
24 |
24 |
p. 6446-6451 6 p. |
artikel |
20 |
Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic β-hairpin peptidomimetic antibiotics containing N-methylated amino acids
|
Vetterli, Stefan U. |
|
2016 |
24 |
24 |
p. 6332-6339 8 p. |
artikel |
21 |
Tetrodecamycin: An unusual and interesting tetronate antibiotic
|
Gverzdys, Tomas |
|
2016 |
24 |
24 |
p. 6269-6275 7 p. |
artikel |
22 |
The action mechanism of daptomycin
|
Taylor, Scott D. |
|
2016 |
24 |
24 |
p. 6253-6268 16 p. |
artikel |
23 |
The emergence and evolution of antimicrobial resistance: Impact on a global scale
|
Hwang, Andrew Y. |
|
2016 |
24 |
24 |
p. 6440-6445 6 p. |
artikel |
24 |
The solithromycin journey—It is all in the chemistry
|
Fernandes, Prabhavathi |
|
2016 |
24 |
24 |
p. 6420-6428 9 p. |
artikel |